Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Immune Cytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)UnknownNCT03304288
What this trial is testing

The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 168
Testing effectiveness (Phase 2)Study completedNCT00054327
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Case Comprehensive Cancer Center 34
Early research (Phase 1)Looking for participantsNCT06826430
What this trial is testing

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd. 12
Early research (Phase 1)WithdrawnNCT00004114
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT01933035
What this trial is testing

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Who this might be right for
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasia+1 more
Beth Israel Medical Center 50
Testing effectiveness (Phase 2)WithdrawnNCT03965624
What this trial is testing

Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Assistance Publique - Hôpitaux de Paris
Not applicableEnded earlyNCT02050581
What this trial is testing

A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone

Who this might be right for
Idiopathic Thrombocytopenia Purpura
Weill Medical College of Cornell University 72
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Early research (Phase 1)Ended earlyNCT00005787
What this trial is testing

Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaNeutropenia
Northwestern University 3
Testing effectiveness (Phase 2)Study completedNCT01929980
What this trial is testing

Bortezomib to Treat Significant Complication of HSCT

Who this might be right for
Allogeneic Stem Cell TransplantationRefractory Autoimmune Cytopenia(s)
Children's Hospital Medical Center, Cincinnati 4
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00290641
What this trial is testing

Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 68
Testing effectiveness (Phase 2)UnknownNCT01162941
What this trial is testing

Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)

Who this might be right for
Thrombocytopenia
Cooperative Study Group A for Hematology 38
Not applicableStudy completedNCT01672151
What this trial is testing

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
First Affiliated Hospital of Suzhou Medical College 35
Very early researchUnknownNCT06417398
What this trial is testing

Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07687134
What this trial is testing

Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP

Who this might be right for
Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)UnknownNCT05020288
What this trial is testing

A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP

Who this might be right for
Immune ThrombocytopeniaBruton's Tyrosine Kinase
Shandong University 40
Not applicableNot Yet RecruitingNCT07811622
What this trial is testing

Clinical Study of CHT105 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Immune Thrombocytopenia (ITP)
Nanjing Miracle Biotechnology Co., Ltd. 24
Not applicableNo Longer AvailableNCT03363334
What this trial is testing

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals
Next Page